img

Global Gemcitabine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Gemcitabine Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Gemcitabine (CAS 95058-81-4), C9H11F2N3O4, the formula weight is 263.2, and its form is white to yellow powder.
Gemcitabine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Gemcitabine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
Gemcitabine is used as a second-line treatment for patients with advanced pancreatic cancer after fluorouracil failure, and can improve the quality of life of patients. Secondly, it is a first-line application for locally advanced (stage III) and already metastatic (stage IV) non-small cell lung cancer.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Gemcitabine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Lilly France
Hansoh Pharma
Hisun Pharma
Pude Pharma
Qilu Pharma
Jari Pharma
HPGC
Yibantian Pharma
Actavis
Accord Healthcare
Mylan
Novartis
Salius Pharma
Segment by Type
1g/Vial
200mg/Vial

Segment by Application


Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Gemcitabine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Gemcitabine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Gemcitabine industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Gemcitabine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Gemcitabine introduction, etc. Gemcitabine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Gemcitabine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Gemcitabine Market Overview
1.1 Gemcitabine Product Overview
1.2 Gemcitabine Market Segment by Type
1.2.1 1g/Vial
1.2.2 200mg/Vial
1.3 Global Gemcitabine Market Size by Type
1.3.1 Global Gemcitabine Market Size Overview by Type (2024-2034)
1.3.2 Global Gemcitabine Historic Market Size Review by Type (2024-2024)
1.3.3 Global Gemcitabine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Gemcitabine Sales Breakdown by Type (2024-2024)
1.4.2 Europe Gemcitabine Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific Gemcitabine Sales Breakdown by Type (2024-2024)
1.4.4 Latin America Gemcitabine Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa Gemcitabine Sales Breakdown by Type (2024-2024)
2 Global Gemcitabine Market Competition by Company
2.1 Global Top Players by Gemcitabine Sales (2024-2024)
2.2 Global Top Players by Gemcitabine Revenue (2024-2024)
2.3 Global Top Players by Gemcitabine Price (2024-2024)
2.4 Global Top Manufacturers Gemcitabine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Gemcitabine Market Competitive Situation and Trends
2.5.1 Gemcitabine Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Gemcitabine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gemcitabine as of 2022)
2.7 Date of Key Manufacturers Enter into Gemcitabine Market
2.8 Key Manufacturers Gemcitabine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Gemcitabine Status and Outlook by Region
3.1 Global Gemcitabine Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global Gemcitabine Historic Market Size by Region
3.2.1 Global Gemcitabine Sales in Volume by Region (2024-2024)
3.2.2 Global Gemcitabine Sales in Value by Region (2024-2024)
3.2.3 Global Gemcitabine Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global Gemcitabine Forecasted Market Size by Region
3.3.1 Global Gemcitabine Sales in Volume by Region (2024-2034)
3.3.2 Global Gemcitabine Sales in Value by Region (2024-2034)
3.3.3 Global Gemcitabine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Gemcitabine by Application
4.1 Gemcitabine Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Gemcitabine Market Size by Application
4.2.1 Global Gemcitabine Market Size Overview by Application (2024-2034)
4.2.2 Global Gemcitabine Historic Market Size Review by Application (2024-2024)
4.2.3 Global Gemcitabine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Gemcitabine Sales Breakdown by Application (2024-2024)
4.3.2 Europe Gemcitabine Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific Gemcitabine Sales Breakdown by Application (2024-2024)
4.3.4 Latin America Gemcitabine Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa Gemcitabine Sales Breakdown by Application (2024-2024)
5 North America Gemcitabine by Country
5.1 North America Gemcitabine Historic Market Size by Country
5.1.1 North America Gemcitabine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America Gemcitabine Sales in Volume by Country (2024-2024)
5.1.3 North America Gemcitabine Sales in Value by Country (2024-2024)
5.2 North America Gemcitabine Forecasted Market Size by Country
5.2.1 North America Gemcitabine Sales in Volume by Country (2024-2034)
5.2.2 North America Gemcitabine Sales in Value by Country (2024-2034)
6 Europe Gemcitabine by Country
6.1 Europe Gemcitabine Historic Market Size by Country
6.1.1 Europe Gemcitabine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe Gemcitabine Sales in Volume by Country (2024-2024)
6.1.3 Europe Gemcitabine Sales in Value by Country (2024-2024)
6.2 Europe Gemcitabine Forecasted Market Size by Country
6.2.1 Europe Gemcitabine Sales in Volume by Country (2024-2034)
6.2.2 Europe Gemcitabine Sales in Value by Country (2024-2034)
7 Asia-Pacific Gemcitabine by Region
7.1 Asia-Pacific Gemcitabine Historic Market Size by Region
7.1.1 Asia-Pacific Gemcitabine Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific Gemcitabine Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific Gemcitabine Sales in Value by Region (2024-2024)
7.2 Asia-Pacific Gemcitabine Forecasted Market Size by Region
7.2.1 Asia-Pacific Gemcitabine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Gemcitabine Sales in Value by Region (2024-2034)
8 Latin America Gemcitabine by Country
8.1 Latin America Gemcitabine Historic Market Size by Country
8.1.1 Latin America Gemcitabine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America Gemcitabine Sales in Volume by Country (2024-2024)
8.1.3 Latin America Gemcitabine Sales in Value by Country (2024-2024)
8.2 Latin America Gemcitabine Forecasted Market Size by Country
8.2.1 Latin America Gemcitabine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Gemcitabine Sales in Value by Country (2024-2034)
9 Middle East and Africa Gemcitabine by Country
9.1 Middle East and Africa Gemcitabine Historic Market Size by Country
9.1.1 Middle East and Africa Gemcitabine Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa Gemcitabine Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa Gemcitabine Sales in Value by Country (2024-2024)
9.2 Middle East and Africa Gemcitabine Forecasted Market Size by Country
9.2.1 Middle East and Africa Gemcitabine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Gemcitabine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Lilly France
10.1.1 Lilly France Company Information
10.1.2 Lilly France Introduction and Business Overview
10.1.3 Lilly France Gemcitabine Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Lilly France Gemcitabine Products Offered
10.1.5 Lilly France Recent Development
10.2 Hansoh Pharma
10.2.1 Hansoh Pharma Company Information
10.2.2 Hansoh Pharma Introduction and Business Overview
10.2.3 Hansoh Pharma Gemcitabine Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Hansoh Pharma Gemcitabine Products Offered
10.2.5 Hansoh Pharma Recent Development
10.3 Hisun Pharma
10.3.1 Hisun Pharma Company Information
10.3.2 Hisun Pharma Introduction and Business Overview
10.3.3 Hisun Pharma Gemcitabine Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Hisun Pharma Gemcitabine Products Offered
10.3.5 Hisun Pharma Recent Development
10.4 Pude Pharma
10.4.1 Pude Pharma Company Information
10.4.2 Pude Pharma Introduction and Business Overview
10.4.3 Pude Pharma Gemcitabine Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Pude Pharma Gemcitabine Products Offered
10.4.5 Pude Pharma Recent Development
10.5 Qilu Pharma
10.5.1 Qilu Pharma Company Information
10.5.2 Qilu Pharma Introduction and Business Overview
10.5.3 Qilu Pharma Gemcitabine Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Qilu Pharma Gemcitabine Products Offered
10.5.5 Qilu Pharma Recent Development
10.6 Jari Pharma
10.6.1 Jari Pharma Company Information
10.6.2 Jari Pharma Introduction and Business Overview
10.6.3 Jari Pharma Gemcitabine Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Jari Pharma Gemcitabine Products Offered
10.6.5 Jari Pharma Recent Development
10.7 HPGC
10.7.1 HPGC Company Information
10.7.2 HPGC Introduction and Business Overview
10.7.3 HPGC Gemcitabine Sales, Revenue and Gross Margin (2024-2024)
10.7.4 HPGC Gemcitabine Products Offered
10.7.5 HPGC Recent Development
10.8 Yibantian Pharma
10.8.1 Yibantian Pharma Company Information
10.8.2 Yibantian Pharma Introduction and Business Overview
10.8.3 Yibantian Pharma Gemcitabine Sales, Revenue and Gross Margin (2024-2024)
10.8.4 Yibantian Pharma Gemcitabine Products Offered
10.8.5 Yibantian Pharma Recent Development
10.9 Actavis
10.9.1 Actavis Company Information
10.9.2 Actavis Introduction and Business Overview
10.9.3 Actavis Gemcitabine Sales, Revenue and Gross Margin (2024-2024)
10.9.4 Actavis Gemcitabine Products Offered
10.9.5 Actavis Recent Development
10.10 Accord Healthcare
10.10.1 Accord Healthcare Company Information
10.10.2 Accord Healthcare Introduction and Business Overview
10.10.3 Accord Healthcare Gemcitabine Sales, Revenue and Gross Margin (2024-2024)
10.10.4 Accord Healthcare Gemcitabine Products Offered
10.10.5 Accord Healthcare Recent Development
10.11 Mylan
10.11.1 Mylan Company Information
10.11.2 Mylan Introduction and Business Overview
10.11.3 Mylan Gemcitabine Sales, Revenue and Gross Margin (2024-2024)
10.11.4 Mylan Gemcitabine Products Offered
10.11.5 Mylan Recent Development
10.12 Novartis
10.12.1 Novartis Company Information
10.12.2 Novartis Introduction and Business Overview
10.12.3 Novartis Gemcitabine Sales, Revenue and Gross Margin (2024-2024)
10.12.4 Novartis Gemcitabine Products Offered
10.12.5 Novartis Recent Development
10.13 Salius Pharma
10.13.1 Salius Pharma Company Information
10.13.2 Salius Pharma Introduction and Business Overview
10.13.3 Salius Pharma Gemcitabine Sales, Revenue and Gross Margin (2024-2024)
10.13.4 Salius Pharma Gemcitabine Products Offered
10.13.5 Salius Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Gemcitabine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Gemcitabine Industrial Chain Analysis
11.4 Gemcitabine Market Dynamics
11.4.1 Gemcitabine Industry Trends
11.4.2 Gemcitabine Market Drivers
11.4.3 Gemcitabine Market Challenges
11.4.4 Gemcitabine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Gemcitabine Distributors
12.3 Gemcitabine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 1g/Vial
Table 2. Major Company of 200mg/Vial
Table 3. Global Gemcitabine Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global Gemcitabine Sales by Type (2024-2024) & (Kg)
Table 5. Global Gemcitabine Sales Market Share in Volume by Type (2024-2024)
Table 6. Global Gemcitabine Sales by Type (2024-2024) & (US& Million)
Table 7. Global Gemcitabine Market Share in Value by Type (2024-2024)
Table 8. Global Gemcitabine Price by Type (2024-2024) & (USD/Kg)
Table 9. Global Gemcitabine Sales by Type (2024-2034) & (Kg)
Table 10. Global Gemcitabine Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Gemcitabine Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Gemcitabine Sales Market Share in Value by Type (2024-2034)
Table 13. Global Gemcitabine Price by Type (2024-2034) & (USD/Kg)
Table 14. North America Gemcitabine Sales by Type (2024-2024) & (Kg)
Table 15. North America Gemcitabine Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe Gemcitabine Sales (Kg) by Type (2024-2024)
Table 17. Europe Gemcitabine Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific Gemcitabine Sales (Kg) by Type (2024-2024)
Table 19. Asia-Pacific Gemcitabine Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America Gemcitabine Sales (Kg) by Type (2024-2024)
Table 21. Latin America Gemcitabine Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa Gemcitabine Sales (Kg) by Type (2024-2024)
Table 23. Middle East and Africa Gemcitabine Sales by Type (2024-2024) & (US$ Million)
Table 24. Global Gemcitabine Sales by Company (2024-2024) & (Kg)
Table 25. Global Gemcitabine Sales Share by Company (2024-2024)
Table 26. Global Gemcitabine Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global Gemcitabine Revenue Share by Company (2024-2024)
Table 28. Global Market Gemcitabine Price by Company (2024-2024) & (USD/Kg)
Table 29. Global Gemcitabine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Gemcitabine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gemcitabine as of 2022)
Table 32. Date of Key Manufacturers Enter into Gemcitabine Market
Table 33. Key Manufacturers Gemcitabine Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Gemcitabine Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global Gemcitabine Sales by Region (2024-2024) & (Kg)
Table 37. Global Gemcitabine Sales Market Share in Volume by Region (2024-2024)
Table 38. Global Gemcitabine Sales by Region (2024-2024) & (US$ Million)
Table 39. Global Gemcitabine Sales Market Share in Value by Region (2024-2024)
Table 40. Global Gemcitabine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2024-2024)
Table 41. Global Gemcitabine Sales by Region (2024-2034) & (Kg)
Table 42. Global Gemcitabine Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Gemcitabine Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Gemcitabine Sales Market Share in Value by Region (2024-2034)
Table 45. Global Gemcitabine Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2024-2034)
Table 46. Global Gemcitabine Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global Gemcitabine Sales by Application (2024-2024) & (Kg)
Table 48. Global Gemcitabine Sales Market Share in Volume by Application (2024-2024)
Table 49. Global Gemcitabine Sales by Application (2024-2024) & (US$ Million)
Table 50. Global Gemcitabine Sales Market Share in Value by Application (2024-2024)
Table 51. Global Gemcitabine Price by Application (2024-2024) & (USD/Kg)
Table 52. Global Gemcitabine Sales by Application (2024-2034) & (Kg)
Table 53. Global Gemcitabine Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Gemcitabine Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Gemcitabine Sales Market Share in Value by Application (2024-2034)
Table 56. Global Gemcitabine Price by Application (2024-2034) & (USD/Kg)
Table 57. North America Gemcitabine Sales by Application (2024-2024) (Kg)
Table 58. North America Gemcitabine Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe Gemcitabine Sales by Application (2024-2024) (Kg)
Table 60. Europe Gemcitabine Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific Gemcitabine Sales by Application (2024-2024) (Kg)
Table 62. Asia-Pacific Gemcitabine Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America Gemcitabine Sales by Application (2024-2024) (Kg)
Table 64. Latin America Gemcitabine Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa Gemcitabine Sales by Application (2024-2024) (Kg)
Table 66. Middle East and Africa Gemcitabine Sales by Application (2024-2024) & (US$ Million)
Table 67. North America Gemcitabine Sales by Country (2024-2024) & (Kg)
Table 68. North America Gemcitabine Sales Market Share in Volume by Country (2024-2024)
Table 69. North America Gemcitabine Sales by Country (2024-2024) & (US$ Million)
Table 70. North America Gemcitabine Sales Market Share in Value by Country (2024-2024)
Table 71. North America Gemcitabine Sales by Country (2024-2034) & (Kg)
Table 72. North America Gemcitabine Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Gemcitabine Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Gemcitabine Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Gemcitabine Sales by Country (2024-2024) & (Kg)
Table 76. Europe Gemcitabine Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe Gemcitabine Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe Gemcitabine Sales Market Share in Value by Country (2024-2024)
Table 79. Europe Gemcitabine Sales by Country (2024-2034) & (Kg)
Table 80. Europe Gemcitabine Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Gemcitabine Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Gemcitabine Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Gemcitabine Sales by Region (2024-2024) & (Kg)
Table 84. Asia-Pacific Gemcitabine Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific Gemcitabine Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific Gemcitabine Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific Gemcitabine Sales by Region (2024-2034) & (Kg)
Table 88. Asia-Pacific Gemcitabine Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Gemcitabine Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Gemcitabine Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Gemcitabine Sales by Country (2024-2024) & (Kg)
Table 92. Latin America Gemcitabine Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America Gemcitabine Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America Gemcitabine Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America Gemcitabine Sales by Country (2024-2034) & (Kg)
Table 96. Latin America Gemcitabine Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Gemcitabine Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Gemcitabine Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Gemcitabine Sales by Country (2024-2024) & (Kg)
Table 100. Middle East and Africa Gemcitabine Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa Gemcitabine Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa Gemcitabine Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa Gemcitabine Sales by Country (2024-2034) & (Kg)
Table 104. Middle East and Africa Gemcitabine Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Gemcitabine Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Gemcitabine Sales Market Share in Value by Country (2024-2034)
Table 107. Lilly France Company Information
Table 108. Lilly France Introduction and Business Overview
Table 109. Lilly France Gemcitabine Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2024-2024)
Table 110. Lilly France Gemcitabine Product
Table 111. Lilly France Recent Development
Table 112. Hansoh Pharma Company Information
Table 113. Hansoh Pharma Introduction and Business Overview
Table 114. Hansoh Pharma Gemcitabine Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2024-2024)
Table 115. Hansoh Pharma Gemcitabine Product
Table 116. Hansoh Pharma Recent Development
Table 117. Hisun Pharma Company Information
Table 118. Hisun Pharma Introduction and Business Overview
Table 119. Hisun Pharma Gemcitabine Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2024-2024)
Table 120. Hisun Pharma Gemcitabine Product
Table 121. Hisun Pharma Recent Development
Table 122. Pude Pharma Company Information
Table 123. Pude Pharma Introduction and Business Overview
Table 124. Pude Pharma Gemcitabine Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2024-2024)
Table 125. Pude Pharma Gemcitabine Product
Table 126. Pude Pharma Recent Development
Table 127. Qilu Pharma Company Information
Table 128. Qilu Pharma Introduction and Business Overview
Table 129. Qilu Pharma Gemcitabine Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2024-2024)
Table 130. Qilu Pharma Gemcitabine Product
Table 131. Qilu Pharma Recent Development
Table 132. Jari Pharma Company Information
Table 133. Jari Pharma Introduction and Business Overview
Table 134. Jari Pharma Gemcitabine Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2024-2024)
Table 135. Jari Pharma Gemcitabine Product
Table 136. Jari Pharma Recent Development
Table 137. HPGC Company Information
Table 138. HPGC Introduction and Business Overview
Table 139. HPGC Gemcitabine Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2024-2024)
Table 140. HPGC Gemcitabine Product
Table 141. HPGC Recent Development
Table 142. Yibantian Pharma Company Information
Table 143. Yibantian Pharma Introduction and Business Overview
Table 144. Yibantian Pharma Gemcitabine Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2024-2024)
Table 145. Yibantian Pharma Gemcitabine Product
Table 146. Yibantian Pharma Recent Development
Table 147. Actavis Company Information
Table 148. Actavis Introduction and Business Overview
Table 149. Actavis Gemcitabine Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2024-2024)
Table 150. Actavis Gemcitabine Product
Table 151. Actavis Recent Development
Table 152. Accord Healthcare Company Information
Table 153. Accord Healthcare Introduction and Business Overview
Table 154. Accord Healthcare Gemcitabine Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2024-2024)
Table 155. Accord Healthcare Gemcitabine Product
Table 156. Accord Healthcare Recent Development
Table 157. Mylan Company Information
Table 158. Mylan Introduction and Business Overview
Table 159. Mylan Gemcitabine Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2024-2024)
Table 160. Mylan Gemcitabine Product
Table 161. Mylan Recent Development
Table 162. Novartis Company Information
Table 163. Novartis Introduction and Business Overview
Table 164. Novartis Gemcitabine Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2024-2024)
Table 165. Novartis Gemcitabine Product
Table 166. Novartis Recent Development
Table 167. Salius Pharma Company Information
Table 168. Salius Pharma Introduction and Business Overview
Table 169. Salius Pharma Gemcitabine Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2024-2024)
Table 170. Salius Pharma Gemcitabine Product
Table 171. Salius Pharma Recent Development
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Gemcitabine Market Trends
Table 175. Gemcitabine Market Drivers
Table 176. Gemcitabine Market Challenges
Table 177. Gemcitabine Market Restraints
Table 178. Gemcitabine Distributors List
Table 179. Gemcitabine Downstream Customers
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Gemcitabine Product Picture
Figure 2. Global Gemcitabine Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Gemcitabine Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global Gemcitabine Sales Status and Outlook (2024-2034) & (Kg)
Figure 5. Product Picture of 1g/Vial
Figure 6. Global 1g/Vial Sales YoY Growth (2024-2034) & (Kg)
Figure 7. Product Picture of 200mg/Vial
Figure 8. Global 200mg/Vial Sales YoY Growth (2024-2034) & (Kg)
Figure 9. Global Gemcitabine Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global Gemcitabine Sales Market Share by Type in 2022 & 2034
Figure 11. North America Gemcitabine Sales Market Share in Volume by Type in 2022
Figure 12. North America Gemcitabine Sales Market Share in Value by Type in 2022
Figure 13. Europe Gemcitabine Sales Market Share in Volume by Type in 2022
Figure 14. Europe Gemcitabine Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Gemcitabine Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Gemcitabine Sales Market Share in Value by Type in 2022
Figure 17. Latin America Gemcitabine Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Gemcitabine Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Gemcitabine Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Gemcitabine Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Gemcitabine Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Gemcitabine Revenue in 2022
Figure 23. Gemcitabine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Hospital Pharmacies
Figure 25. Global Hospital Pharmacies Sales YoY Growth (2024-2034) & (Kg)
Figure 26. Product Picture of Retail Pharmacies
Figure 27. Global Retail Pharmacies Sales YoY Growth (2024-2034) & (Kg)
Figure 28. Product Picture of Online Pharmacies
Figure 29. Global Online Pharmacies Sales YoY Growth (2024-2034) & (Kg)
Figure 30. Global Gemcitabine Sales by Application (2024-2034) & (US$ Million)
Figure 31. Global Gemcitabine Sales Market Share by Application in 2022 & 2034
Figure 32. North America Gemcitabine Sales Market Share in Volume by Application in 2022
Figure 33. North America Gemcitabine Sales Market Share in Value by Application in 2022
Figure 34. Europe Gemcitabine Sales Market Share in Volume by Application in 2022
Figure 35. Europe Gemcitabine Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Gemcitabine Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Gemcitabine Sales Market Share in Value by Application in 2022
Figure 38. Latin America Gemcitabine Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Gemcitabine Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Gemcitabine Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Gemcitabine Manufacturing Cost Structure
Figure 43. Gemcitabine Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed